Atlas Trials

Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers

Clinical trial NCT05532293 · COMPLETED

Trial details

NCT number
NCT05532293
Sponsor
Godavari Biorefineries Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2022-12-02
Primary completion
2025-11-10
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.